We subsequently created a more unique probe, [18F]CFA, which was Utilized in the current review to evaluate dCK exercise in tumors when handled with a small molecule dCK inhibitor. This probe is usually currently being studied inside a medical demo at our institution to evaluate variations in dCK activity subsequent most cancers immunotherapy 18. P